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Abstract
Introduction: Cardiogenic shock is very uncommon in healthy people. The differential diagnosis for patients with
acute heart failure in previously healthy hearts includes acute myocardial infarction and myocarditis. However,
many drugs can also depress myocardial function. Propofol and fentanyl are frequently used during different
medical procedures. The cardiovascular depressive effect of both drugs has been well established, but the
development of cardiogenic shock is very rare when these agents are used.
Case presentation: After a minor surgical intervention, a 32-year-old Caucasian woman with no significant medical
history went into sudden hemodynamic deterioration due to acute heart failure. An urgent echocardiogram
showed severe biventricular dysfunction and an estimated left ventricular ejection fraction of 20%. Extracorporeal
life support and mechanical ventilation were required. Five days later her ventricular function had fully recovered,
which allowed the progressive withdrawal of medical treatment. Prior to her hospital discharge, cardiac MRI
showed neither edema nor pathological deposits on the delayed contrast enhancement sequences. At her six-
month follow-up examination, the patient was asymptomatic and did not require treatment.
Conclusion: Although there are many causes of cardiogenic shock, the presence of abrupt hemodynamic
deterioration and the absence of a clear cause could be related to the use of propofol and fentanyl.
Introduction
Cardiogenic shock is the most serious form of presenta-
tion of heart failure (HF). The anticipation of hemody-
namic deterioration and multiple organ failure in these
patients is very important in terms of survival. The out-
come for patients with refractory acute cardiogenic
shock remains disproportionately poor. Technological
advances in recent years have enabled the development
of new treatments, such as extracorporeal life support
(ELS). ELS is a variation of cardiopulmonary bypass
which could improve the outcomes of patients in car-
diogenic shock [1]. Although ischemic heart disease is
the most common cause, there are many other etiolo-
gies [2]. Some drugs commonly used for sedation and
analgesia during surgical procedures, as frequently as
electrical cardioversion or transesophageal echocardio-
graphy, may have undesirable effects on cardiac
hemodynamics. Propofol and fentanyl could depress
myocardial function, but the effect of these agents on
left ventricular ejection fraction (LVEF) in patients with
normal left ventricle function has been reported to be
mildly reduced [3,4]. The development of cardiogenic
shock in patients treated with these drugs is a very
uncommon situation.
Case presentation
We report the case of a 32-year-old Caucasian woman
who experienced sudden, severe hemodynamic deteriora-
tion after undergoing a minor surgical procedure. Her
medical history was unremarkable except for a vaginal
delivery two years before. She underwent surgery to
remove a Bartholin cyst, and no infection in the gland was
found. The operation was performed while the patient was
under sedation and being given an analgesic. Spontaneous
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any medium, provided the original work is properly cited.breathing was maintained by infusing a propofol bolus (1
mg/kg) and fentanyl 100 μg intravenously. During surgery,
the patient remained hemodynamically stable. She has
nausea and vomiting in the early post-operative period,
which were treated with intravenous ondansetron (4 mg).
A few minutes later the patient went into sudden hemody-
namic deterioration, with sinus tachycardia (113 regular
beats/minute) and hypotension (50/30 mmHg). Pulse oxi-
metry showed that her oxygen saturation level had
decreased to 80% despite oxygen supplementation through
a face mask (fraction of inspired oxygen 40%). In this clini-
cal situation, we treated her with intravenous dopamine
and dobutamine, as well as with mechanical ventilation
because of global respiratory failure (arterial gasometry:
oxygen pressure 40 mmHg, carbon dioxide pressure 49
mmHg). The electrocardiogram showed sinus tachycardia.
Signs of HF were found on her chest X-ray, and urgent
transthoracic echocardiography (TTE) revealed severe
biventricular dysfunction with global hypokinesia and a
LVEF estimated to be 35%. Coronary angiography showed
no coronary lesions, and an intra-aortic balloon pump was
inserted for counterpulsation. Repeat TTE revealed a
LVEF of 20% with a dilated left ventricle (Figure 1A and
Additional files 1 and 2, movies 1 and 2). Because of the
Figure 1 Ecocardiographic images: (A) Transthoracic echocardiogram showing severe left ventricular dysfunction. (B) Normal LVEF after total
recovery.
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corporeal membrane oxygenation (ECMO) assistance
device was inserted. After the fifth day, the patient’sg r a -
dual recovery of LVEF led to the withdrawal of circulatory
support and mechanical ventilation. Three weeks later a
new TTE showed a non-dilated left ventricle, an absence
of segmental contractility alterations, and a LVEF in the
normal range (Figure 1B and Additional files 3 and 4,
movies 3 and 4). The maximum value of troponin T was
0.60 ng/ml, and the C-reactive protein level was 6 mg/L.
The patient’s basic chemistry panel, complete blood cell
count, and coagulation profile were within normal limits.
The serology battery for myocarditis, blood cultures, urine
cultures, and cytotoxic antibodies were all negative. An
endomyocardial biopsy was not performed because of its
low diagnostic yield. Prior to the patient’s discharge, car-
diac MRI was performed, which showed a preserved LVEF
(Figure 2). Neither interstitial edema nor pathological
deposits in the delayed enhancement sequences were seen.
At her six-month follow-up examination, the patient was
asymptomatic and did not require further treatment.
Discussion
To establish the causal diagnosis of HF, it is necessary to
determine whether the clinical presentation is a de novo
process or a chronic entity exacerbated by surgery. In our
patient, the absence of ventricular remodeling visualized
by TTE suggests the former postulate. Regarding its etiol-
ogy, many possibilities should be taken into account. Post-
partum cardiomyopathy usually develops in late pregnancy
or during the first months after delivery [5]. In our patient,
childbirth was very unlikely the cause of her acute HF as
delivery had occurred two years before. A viral infection
could justify the clinical context of acute myocarditis [6],
but her sudden clinical deterioration, with no history of
infection or negative serologies and lack of typical findings
on MRI, makes this diagnosis unlikely. Propofol infusion
syndrome includes arrhythmias, hemodynamic deteriora-
tion, metabolic acidosis, rhabdomyolysis, and impaired
renal and hepatic function. This clinical entity has been
described mainly in pediatric critical care patients and has
been associated with prolonged use (>48 hours) and high
doses (>4 mg/kg/hour) [7]. Ondansetron is a 5-hydroxy-
tryptamine type 3 (5-HT3) receptor antagonist used
mainly as an anti-emetic. Although considered a safe class
of medications by many clinicians, several of the 5-HT3
receptor antagonists have been associated with adverse
cardiovascular effects [8]. There is a rare possibility of con-
vulsions, chest pain, arrhythmias, hypotension, or brady-
cardia associated with using ondansetron, but we have not
found any case in the literature describing a connection
between the use of this drug in the post-operative and the
development of HF. Takotsubo cardiomyopathy (TTC) is
an acute cardiac syndrome mimicking elevated ST-seg-
ment myocardial infarction characterized by transient
regional wall motion abnormalities involving the apical
and middle portions of the left ventricle in the absence of
significant obstructive coronary disease [9]. Recently, an
apical sparing variant defined as akinesia of the basal and
middle segments of all walls has been described [10]. In
our patient, the absence of electrocardiographic and echo-
cardiographic alterations suggestive of TTC leads us to
reject this diagnostic possibility. The association of propo-
fol and fentanyl as a cause of severe, acute HF has been
described previously [11]. Other than the case described
by Chow et al. [11], however, we have not found another
case report in the literature that mentions the combination
of these drugs as a cause of severe, acute HF due to ventri-
cular dysfunction in patients with healthy hearts. In this
regard, both propofol and fentanyl may cause depression
of ventricular function and decreased blood pressure. Pro-
pofol dilates the arteries by inducing nitric oxide synthesis,
blocks calcium channels, and activates protein kinase C,
all of which, taken together, lead to a decrease in pre-load
and a decline in cardiac output. Apart from this possibility,
an intrinsic negative inotropic effect attributable to propo-
fol itself has also been reported [4,12]. This effect is dose-
dependent [13]. It occurs most often when used in
Figure 2 Cardiac-MRI images: (A) Cardiac MRI gradient echo sequence showing normal dimensions and function of the left ventricle. (B) T2-
weighted short τ inversion recovery sequence showing the absence of edema. (C) Late gadolinium hyperenhancement sequence without
pathological contrast captation.
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previous heart disease [4]. Both mechanisms might trigger
a state of cardiogenic shock in patients with individual sus-
ceptibility. When these agents are used in combination,
additional precautions should be taken in all patients,
including those with normal left ventricular function.
Because of refractory cardiogenic shock, ELS was needed
in our patient. ELS should be considered in patients with
severe, life-threatening respiratory or cardiac failure that
does not respond to conventional intensive care manage-
ment [1]. Currently, several options are available for circu-
latory support, including surgically implanted ventricular
assistance devices, percutaneous assistance devices, and
E C M O[ 1 4 ] .I no u rc a s e ,E C M Op r o v i d e dr e a s o n a b l e
short-term support, allowing the patient to recover from
multi-organ injury and increasing the time to complete a
transplant evaluation if necessary. The use of this device is
a support modality rather than a treatment in itself. As it
requires well-trained personnel and is not without risk,
selection of patients in whom this device can be used is
required. So, the disease process must be reversible, or,
failing this, the patient should be a candidate for trans-
plantation or insertion of a ventricular assistance device.
Conclusions
In conclusion, the final etiological diagnosis of our
patient is uncertain. Her severe, acute hemodynamic
deterioration due to acute heart failure seems to have
been causally related to some event that occurred during
the peri-operative period. Propofol and fentanyl are
often used during different medical procedures. The
effects previously described, although uncommon,
should be taken into account in cases of abrupt hemo-
dynamic deterioration and an absence of other possible
causes. ECMO is an effective salvage strategy for the
treatment of patients with extreme hemodynamic
instability and multi-organ injury due to acute HF.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Additional material
Additional file 1: Apical view image showing severe left ventricular
dysfunction. Transthoracic echocardiography (apical four-chamber view)
showing severe left ventricular dysfunction during the acute phase.
Additional file 2: Short-axis view showing severe left ventricular
dysfunction. Transthoracic echocardiography (paraesternal short-axis
view) showing severe left ventricular dysfunction during the acute phase.
Additional file 3: Apical four-chamber view after total recovery of
left ventricular function. Transthoracic echocardiography (apical four-
chamber view) showing total recovery of left ventricular function before
discharge.
Additional file 4: Short-axis view after total recovery of left
ventricular function. Transthoracic echocardiography (paraesternal
short-axis view) showing total recovery of left ventricular function before
discharge.
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